Department of Obstetrics and Gynecology, University of Calgary, Calgary, Alberta, Canada.
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada.
Neurourol Urodyn. 2018 Aug;37(6):1965-1970. doi: 10.1002/nau.23541. Epub 2018 Jun 4.
Uterine fibroids are the most common tumor of the female reproductive tract [Baird et al Am J Obstet Gynecol. 188:100-107, 2003] and bladder symptoms are more prevalent in these women [Pron et al Fertil Steril. 79:112-119, 2003; Volkers et al Am J Obstet Gynecol. 196:519.e1-e11, 2007] However, the effect of various fibroid debulking surgeries on different types of urinary incontinence symptoms is poorly understood. Our primary objective was to determine whether surgical debulking of uterine fibroids affects urinary symptoms. Secondary objectives were: to define the baseline prevalence of bladder symptoms in women undergoing fibroid surgery; to explore links between fibroid characteristics, size of debulked fibroids, type of surgery, and postoperative changes in bladder function.
Prospective cohort study (2011-2016) of women undergoing vaginal or abdominal myomectomy or hysterectomy. Baseline demographics were obtained. All women underwent a detailed pelvic ultrasound preoperatively. The Urinary Distress Inventory (UDI) questionnaire of the validated Pelvic Floor Distress Inventory (PFDI) was administered before and 6 weeks after surgery. Score changes were assessed using Wilcoxon signed rank test.
Sixty-one women completed the study. At baseline, regardless of fibroid characteristics, 96.6% of women had various bothersome urinary symptoms including storage, voiding, and incontinence. Following surgical fibroid debulking, median improvement in the UDI total score was clinically and statistically significant at 39.9 (P < 0.001). All urinary subscale scores were also significantly improved. 11/17 women (64.7%) and 11/18 women (61.1%) were cured of moderately to severely bothersome symptoms of urge and stress urinary incontinence respectively.
Urinary symptoms are common in women undergoing surgery for uterine fibroids. Fibroid debulking may be offered as treatment for bladder symptoms in symptomatic women.
子宫肌瘤是女性生殖道最常见的肿瘤[Baird 等人,《美国妇产科杂志》。188:100-107, 2003],这些女性更常出现膀胱症状[Pron 等人,《生育与不孕》。79:112-119, 2003; Volkers 等人,《美国妇产科杂志》。196:519.e1-e11, 2007]。然而,各种子宫肌瘤切除术对不同类型的尿失禁症状的影响知之甚少。我们的主要目的是确定子宫肌瘤切除术是否会影响尿失禁症状。次要目标是:确定接受子宫肌瘤手术的女性中膀胱症状的基线患病率;探讨子宫肌瘤特征、切除肌瘤的大小、手术类型与术后膀胱功能变化之间的联系。
前瞻性队列研究(2011-2016 年),研究对象为接受阴道或腹部子宫肌瘤切除术或子宫切除术的女性。记录基线人口统计学资料。所有女性均在术前接受详细的盆腔超声检查。使用经过验证的《盆底窘迫问卷》(Pelvic Floor Distress Inventory,PFDI)中的《尿窘迫问卷》(Urinary Distress Inventory,UDI)对患者进行问卷调查。采用 Wilcoxon 符号秩检验评估手术前后的评分变化。
61 名女性完成了研究。基线时,无论子宫肌瘤特征如何,96.6%的女性都有各种恼人的尿失禁症状,包括储存、排空和失禁。在接受手术性子宫肌瘤剔除术后,UDI 总分的中位数改善具有临床和统计学意义(39.9,P<0.001)。所有尿失禁亚量表评分均显著改善。17 名女性中有 11 名(64.7%)和 18 名女性中有 11 名(61.1%)分别治愈了中度至重度急迫性和压力性尿失禁症状。
接受子宫肌瘤切除术的女性常有尿失禁症状。对于有膀胱症状的症状性女性,可考虑进行子宫肌瘤剔除术治疗膀胱症状。